Biomarin Pharmaceutical (BMRN) Change in Intangibles (2019 - 2025)

Biomarin Pharmaceutical has disclosed Change in Intangibles across 7 years of filings, most recently posting $2.4 million for Q4 2025.

• Quarterly Change in Intangibles rose 207.93% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (down 33.83% YoY) and the FY2025 annual result came in at $7.9 million, down 33.83% from the prior year.
• Change in Intangibles eased to $2.4 million in Q4 2025, from $5.3 million in the prior quarter.
• Over five years, Change in Intangibles peaked at $15.6 million in Q4 2021 and troughed at $266000.0 in Q2 2025.
• A 5-year average of $3.4 million and a median of $1.9 million in 2022 frame the typical range for Change in Intangibles.
• Annual changes were most pronounced in 2022 — Change in Intangibles slumped 95.7% — and 2024, when it jumped 2480.65%.
• Tracing BMRN's Change in Intangibles over 5 years: stood at $15.6 million in 2021, then sank by 95.7% to $671000.0 in 2022, then soared by 1059.31% to $7.8 million in 2023, then slumped by 90.11% to $769000.0 in 2024, then jumped by 207.93% to $2.4 million in 2025.
• Business Quant data shows BMRN's Change in Intangibles at $2.4 million in Q4 2025, $5.3 million in Q3 2025, and $266000.0 in Q2 2025.